Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
31.48
-0.45 (-1.41%)
Oct 30, 2026, 4:00 PM EST - Market closed
Maze Therapeutics Revenue
Maze Therapeutics had revenue of $20.00M in the twelve months ending June 30, 2026, up 700.00% year-over-year. That makes Maze Therapeutics the 33,853rd largest company in the world by revenue and 4,445th in the United States.
Revenue (ttm)
$20.00M
Revenue Growth
+700.00%
P/S Ratio
84.89
Revenue / Employee
$141,844
Employees
141
Market Cap
1.70B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 167.50M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
MAZE News
- 14 days ago - Maze Therapeutics initiated with a Buy at Canaccord - TheFly
- 26 days ago - Maze Therapeutics to Present Data from MZE829 and MZE782 Programs at ASN Kidney Week 2026 - GlobeNewsWire
- 5 weeks ago - Maze Therapeutics initiated with a Buy at Citi - TheFly
- 5 weeks ago - Vertex's Kidney Drug Success Sparks a 22% Surge for This Rival Biotech - Barrons
- 6 weeks ago - Maze Therapeutics Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 7 weeks ago - Maze Therapeutics Transcript: Citigroup’s Biopharma Back to School Summit 2026 - Transcripts
- 7 weeks ago - Maze Therapeutics Transcript: Wells Fargo 21st Annual Healthcare Conference - Transcripts
- 2 months ago - Maze Therapeutics to Participate in Three Upcoming Investor Conferences - GlobeNewsWire